Approvals.
- Published in:
- Brown University Psychopharmacology Update, 2021, v. 32, n. 9, p. 8, doi. 10.1002/pu.30774
- Publication type:
- Article
Works matching IS 10685308 AND DT 2021 AND VI 32 AND IP 9
Results: 12
1
2
Opioid agonist drugs associated with reduced mortality risk.
- Published in:
- Brown University Psychopharmacology Update, 2021, v. 32, n. 9, p. 4, doi. 10.1002/pu.30768
- Publication type:
- Article
3
Your Medication Information.
- Published in:
- Brown University Psychopharmacology Update, 2021, v. 32, n. 9, p. 9, doi. 10.1002/pu.30775
- Publication type:
- Article
4
Extended‐release viloxazine improves symptoms in adolescents with ADHD.
- Published in:
- Brown University Psychopharmacology Update, 2021, v. 32, n. 9, p. 3, doi. 10.1002/pu.30767
- Publication type:
- Article
5
Association of clozapine metabolism and neutropenia.
- Published in:
- Brown University Psychopharmacology Update, 2021, v. 32, n. 9, p. 2, doi. 10.1002/pu.30766
- Publication type:
- Article
6
The end of the buprenorphine waiver.
- Published in:
- Brown University Psychopharmacology Update, 2021, v. 32, n. 9, p. 7, doi. 10.1002/pu.30773
- Publication type:
- Article
7
No benefit from intranasal oxytocin for negative symptoms in schizophrenia.
- Published in:
- Brown University Psychopharmacology Update, 2021, v. 32, n. 9, p. 8, doi. 10.1002/pu.30772
- Publication type:
- Article
8
Anticholinergic medication burden linked to cognitive impairment in schizophrenia.
- Published in:
- Brown University Psychopharmacology Update, 2021, v. 32, n. 9, p. 8, doi. 10.1002/pu.30771
- Publication type:
- Article
9
Two drug classes show benefit for young children with ADHD.
- Published in:
- Brown University Psychopharmacology Update, 2021, v. 32, n. 9, p. 6, doi. 10.1002/pu.30770
- Publication type:
- Article
10
Monthly paliperidone improves outcomes for Blacks with criminal justice involvement.
- Published in:
- Brown University Psychopharmacology Update, 2021, v. 32, n. 9, p. 6, doi. 10.1002/pu.30769
- Publication type:
- Article
11
Psychological treatment for depression may be viable for relapse prevention.
- Published in:
- Brown University Psychopharmacology Update, 2021, v. 32, n. 9, p. 1, doi. 10.1002/pu.30764
- Publication type:
- Article
12
Reducing antipsychotic dose has risk in treating multi‐episode schizophrenia.
- Published in:
- Brown University Psychopharmacology Update, 2021, v. 32, n. 9, p. 1, doi. 10.1002/pu.30765
- Publication type:
- Article